Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with FARE to enhance the safety of children with food allergies. The launch of the initiative, which is informed by survey results, comes one year after the drugmakers won FDA approval for Xolair in people with food allergies.
Genentech and Novartis have teamed up with FARE to enhance the safety of children with food allergies. The launch of the initiative, which is informed by survey results, comes one year after the drugmakers won FDA approval for Xolair in people with food allergies.
